USP7 can increase KDM6A expression by deubiquitinating it, while targeting KDM6A can inhibit tumor growth (Fig. 11).327 Furthermore, the low level of H3K27me3 is closely related to cell stemness and oxaliplatin resistance in colorectal cancer. Here, KDM6A is linked to colorectal cancer.